PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Targeting coagulation factor XII as a novel therapeutic option in brain trauma.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27043916 ↗2016Reported benefit

Targeting coagulation factor XII as a novel therapeutic option in brain trauma.

MouseTBIWeight-drop / impact-accelerationC57BL/6N wild-type, FXII-deficient and FXI-deficient miceMale and femalen = 148 C57BL/6N wild-type mice (134 male, 14 female), 60 FXII-…Intravenous200 mg/kg body weightSingle bolus after injury induction; reconstitution experiments with human FXII…

Model: Weight-drop closed-head injury (concussion-like diffuse TBI) and cortical cryolesion

Both genetic factor XII deficiency and pharmacological inhibition of activated factor XII with rHA-Infestin-4 minimised trauma-induced microvascular thrombus formation and improved outcome, with better motor function, reduced brain lesion volume and diminished neurodegeneration, without increasing…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.